Patent directory · USPTO A61K / A61P
Patents matching “ras”
843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11679075
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
granted -
US 11672774
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
granted -
US 11667692
T cell receptors recognizing HLA-CW8 restricted mutated KRAS
granted -
US 11661411
Quinoxaline compounds and uses thereof
granted -
US 11655248
Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor
granted -
US 11654128
Methods and compositions for treating ectoparasite infestations
granted -
US 11639364
Potent sialyltransferase inhibitors
granted -
US 11617769
Methods of transdifferentiation and methods of use thereof
granted -
US 11607464
Compositions and methods for the treatment and imaging of cancer
granted -
US 11608346
Ras inhibitors
granted -
US 11597948
Use of ANP32 protein in maintaining the polymerase activity of influenza virus in hosts
granted -
IL 300192
Manufacturing of dimeric contrast agents
granted -
US 11583541
Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
granted -
US 11564927
Therapeutic compositions, combinations, and methods of use
granted -
US 11566007
Ras inhibitors
granted -
US 11548888
KRas G12C inhibitors
granted -
US 11541045
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11541044
K-Ras modulators
granted -
US 11542341
Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies
granted -
US 11524962
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
granted -
US 11518750
3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of telomerase
granted -
US 2022370646
PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS
granted -
US 11504427
Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy
granted -
US 11497793
Compositions and methods for treating glioblastoma
granted